Stay updated on Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays the completed Phase 3 study of adjuvant nivolumab and chemotherapy for resected gastric cancer, including study design, eligibility criteria, measured outcomes, and participating locations.
    Difference
    94%
    Check dated 2026-11-08T12:44:00.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0. The study record remains inaccessible and displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T13:14:09.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from using “Artificial Intelligence” to “Super Intelligence” in some content and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T13:16:26.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T13:31:52.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T13:55:58.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    403 Forbidden page now appears where the study record used to be, blocking access to the trial's details. The content is replaced by an error screen, indicating an access restriction rather than the study information.
    Difference
    17%
    Check dated 2026-09-20T19:43:31.000Z thumbnail image

Stay in the know with updates to Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant ONO-4538 in Resected Gastric Cancer Clinical Trial page.